Tedatioxetine hydrobromide inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets α1A-adrenergic receptor, 5-HT2A receptor, 5-HT2C receptor, and 5-HT3 receptor.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.